Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Next-generation Sequencing03:00

Next-generation Sequencing

99.6K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
99.6K
RNA-seq03:21

RNA-seq

12.3K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases. 
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
12.3K
Sanger Sequencing01:57

Sanger Sequencing

776.1K
DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
776.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Short-Term Within-Host Genomic Diversity and Clone Turnover of Carbapenem-Resistant <i>Klebsiella pneumoniae</i> in an Intensive Care Unit Patient.

Antibiotics (Basel, Switzerland)·2026
Same author

TCR repertoire shaping of naïve T cell subsets in human ontogeny.

Frontiers in immunology·2026
Same author

Capturing and Tracking Clonal T-cell Response to Cancer Neoantigens.

Cancer immunology research·2026
Same author

Genomic, Evolutionary and Phenotypic Insights into <i>Pseudomonas</i> Phage Adele, a Novel <i>Pakpunavirus</i> with Potential for Phage Therapy.

Viruses·2026
Same author

<i>Bulleidia extructa</i> PP_925: Genome Reduction, Minimalist Metabolism, and Evolutionary Insights into Firmicutes Diversification.

International journal of molecular sciences·2026
Same author

Study Protocol for Genomic Epidemiology Investigation of Intensive Care Unit Patient Colonization by Antimicrobial-Resistant ESKAPE Pathogens.

Methods and protocols·2025

Related Experiment Video

Updated: Mar 3, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

34.9K

MAGERI: Computational pipeline for molecular-barcoded targeted resequencing.

Mikhail Shugay1,2,3, Andrew R Zaretsky1,2,4, Dmitriy A Shagin1,2

  • 1Shemyakin-Ovchinnikov Institute of bioorganic chemistry RAS, Miklukho-Maklaya 16/10, Moscow, Russia.

Plos Computational Biology
|May 6, 2017
PubMed
Summary

Unique molecular identifiers (UMIs) enable accurate rare variant detection in high-throughput sequencing. MAGERI software efficiently processes UMI data for robust mutation profiling and ultra-rare variant identification.

More Related Videos

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.3K
Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
06:40

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

1.8K

Related Experiment Videos

Last Updated: Mar 3, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

34.9K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.3K
Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
06:40

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

1.8K

Area of Science:

  • Genomics
  • Bioinformatics
  • Molecular Biology

Background:

  • Unique molecular identifiers (UMIs) are crucial for high-throughput resequencing, enabling accurate rare variant identification in complex DNA.
  • Applications span cancer diagnostics and other fields, necessitating specialized bioinformatics tools.
  • Existing methods face challenges in handling UMI-based data caveats.

Purpose of the Study:

  • Introduce MAGERI, a computational pipeline for UMI-based sequencing data analysis.
  • Enable high-fidelity mutation profiling and the reliable calling of ultra-rare variants.
  • Provide a robust and efficient solution for UMI data analysis.

Main Methods:

  • Developed a computational pipeline named MAGERI.
  • Utilized extensive benchmark datasets, including gold-standard samples, tumor cell-free DNA, and public UMI-encoded data.
  • Validated performance across different sample types and UMI-based protocols.

Main Results:

  • MAGERI demonstrates robust and efficient performance in calling rare variants.
  • Achieved high-fidelity mutation profiles from UMI-encoded sequencing data.
  • Successfully analyzed both tumor DNA and viral RNA samples.

Conclusions:

  • MAGERI is a versatile and accurate tool for UMI-based sequencing analysis.
  • The pipeline effectively addresses UMI data complexities for rare variant detection.
  • MAGERI supports diverse applications in genomics and diagnostics.